A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03254927 · TERMINATED
Trial details
- NCT number
- NCT03254927
- Sponsor
- Celldex Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2020-09-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.